{"id":"hum0614","secondaryIds":[],"version":1,"url":"https://humandbs.dbcls.jp/research/hum0614/v1","datePublished":"2026-11-17","versions":[{"version":1,"datePublished":"2026-11-17"}],"title":{"ja":"SIGNATURE : A translational omics and patient-tailored strategies for optimized management of childhood cancers in the province of Quebec over the continuum of care.","en":"SIGNATURE : A translational omics and patient-tailored strategies for optimized management of childhood cancers in the province of Quebec over the continuum of care."},"summary":{"aims":{"ja":"SIGNATUREプログラムは、小児腫瘍領域におけるケベック州の精密医療イニシアチブであり、州内の4つの大学附属小児医療センターである、CHU Sainte-Justine および McGill University Health Centre（モントリオール）、CHU de Sherbrooke（エストリー地域）、CHU de Québec–Université Laval（ケベック市）を結集する取り組みである。\nSIGNATUREの目的は、小児および青年期のがんを対象に大規模なゲノムプロファイリングを実施し、臨床的意義を有する可能性のある既知および新規の分子異常を同定するとともに、分子標的治療へのアクセスを検討・支援することである。","en":"The SIGNATURE program is a provincial precision medicine initiative in pediatric oncology that brings together Quebec's four university pediatric centers: CHU Sainte-Justine and the McGill University Health Centre (Montréal), the CHU de Sherbrooke (Estrie), and the CHU de Québec-Université Laval (Québec). SIGNATURE aims to perform large-scale genomic profiling of cancers in children and adolescents to identify known and novel molecular alterations with potential clinical relevance and help guide access to targeted therapies."},"methods":{"ja":"DNA抽出後、Covaris G-tubesを用いてDNAを約12 kbの断片に断片化した。各サンプルは1枚のFLO-PRO114Mフローセルにロードし、CRA-CHUSJ統合ゲノミクス・メタプラットフォーム（Meta-Platform for Integrated Genomics：MPGI）に設置されたPromethION 24を用いてシーケンシングを行った。ライブラリ調製は、Oxford Nanopore Technologies（ONT）社のSQK-LSK114キットを使用し、メーカーのプロトコルに従って実施した。","en":"Following DNA extraction, DNA was sheared to ~12 kb fragments using Covaris G-tubes. Each sample was loaded onto a single FLO-PRO114M flow cell, sequenced on the PromethION 24 at the CRA-CHUSJ Meta-Platform for Integrated Genomics (MPGI). Library preparation was done following the manufacturer's protocol using the SQK-LSK114 kit from Oxford Nanopore Technologies (ONT)."},"targets":{"ja":"SIGNATURE研究に登録された小児がん35症例。\n腫瘍組織31検体および非腫瘍組織4検体（うち横紋筋肉腫1症例1検体は2回シーケンスを実施）","en":"35 patients were enrolled in the SIGNATURE study, initiated in November 2019. Four control samples were derived from non tumoral tissue of participants with a cancer diagnosis (blood or bone marrow)."},"url":{"ja":null,"en":null}},"listingSummary":{"methods":{"ja":"配列決定","en":"Sequencing"},"targets":{"ja":"小児癌：35症例\n（カナダ人）","en":"pediatric center: 35 cases\n(Canadian)"},"typeOfData":{"ja":"NGS\n（Target Capture）","en":"NGS\n(Target Capture)"}},"releaseNote":{"ja":"小児がん35症例の腫瘍組織31検体および非腫瘍組織4検体から抽出したDNAを用いた380領域に対するTarget capture secqunecing 解析データを fastq および bed ファイルにて提供する。","en":"DNAs extracted from tumor tissue and non-tumor tissues from 35 patients with pediatric cancer were used for the target capture sequencing analysis about 380 regions related to cancer. Fastq and bam files are provided."},"dataProviders":[{"name":{"en":"Vincent Philippe Lavallee"},"organization":{"name":{"en":"Hematology, Medicine, Pediatrics, CHU Sainte-Justine"}}}],"researchProjects":[{"name":{"ja":"SIGNATURE project","en":"SIGNATURE project"},"url":{"ja":null,"en":null}}],"grants":[{"title":{"ja":"SIGNATURE project","en":"SIGNATURE project"},"agency":{"ja":"Charles-Bruneau Foundation, CHU Sainte-Justine Foundation","en":"Charles-Bruneau Foundation, CHU Sainte-Justine Foundation"},"grantIds":null},{"title":{"ja":"Precision Child Health Partnership (PCHP)","en":"Precision Child Health Partnership (PCHP)"},"agency":{"ja":"Azrieli Foundation","en":"Azrieli Foundation"},"grantIds":null}],"relatedPublications":[{"title":"Accelerated and Comprehensive Pediatric Cancer Profiling Using Whole-Genome Sequencing with Adaptive Sampling","doi":"https://doi.org/10.1186/s13073-026-01815-7","datasets":["JGAD001136"]}],"datasets":["JGAD001136"],"controlledAccessUsers":[]}